Want to see HK:1312 full AI Analyst Report?
Total Valuation
Kontafarma China Holdings Ltd has a market cap or net worth of HK$150.63M. The enterprise value is HK$186.41M.
Market CapHK$150.63M
Enterprise ValueHK$186.41M
Share Statistics
Kontafarma China Holdings Ltd has 5,588,572,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding5,588,572,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Kontafarma China Holdings Ltd’s return on equity (ROE) is -0.77 and return on invested capital (ROIC) is -33.21%.
Return on Equity (ROE)-0.77
Return on Assets (ROA)-0.40
Return on Invested Capital (ROIC)-33.21%
Return on Capital Employed (ROCE)-0.40
Revenue Per Employee1.46M
Profits Per Employee-727.57K
Employee Count625
Asset Turnover0.86
Inventory Turnover4.41
Valuation Ratios
The current PE Ratio of Kontafarma China Holdings Ltd is ―. Kontafarma China Holdings Ltd’s PEG ratio is -0.00081.
PE Ratio―
PS Ratio0.18
PB Ratio0.29
Price to FCF3.04
Price to Operating Cash Flow5.16
PEG Ratio-0.00081
Income Statement
In the last 12 months, Kontafarma China Holdings Ltd had revenue of 914.71M and earned -427.85M in profits. Earnings per share was -0.08.
Revenue914.71M
Gross Profit513.64M
Operating Income-242.83M
Pretax Income-454.73M
Net Income-427.85M
EBITDA-151.75M
Earnings Per Share (EPS)-0.08
Cash Flow
In the last 12 months, operating cash flow was 29.21M and capital expenditures -19.64M, giving a free cash flow of 9.57M billion.
Operating Cash Flow29.21M
Free Cash Flow9.57M
Free Cash Flow per Share<0.01
Dividends & Yields
Kontafarma China Holdings Ltd pays an annual dividend of HK$0.004, resulting in a dividend yield of 2.96%
Dividend Per ShareHK$0.004
Dividend Yield2.96%
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.32
52-Week Price Change-3.57%
50-Day Moving Average0.03
200-Day Moving Average0.03
Relative Strength Index (RSI)48.24
Average Volume (3m)358.80K
Important Dates
Kontafarma China Holdings Ltd upcoming earnings date is Apr 1, 2027, TBA (Confirmed).
Last Earnings DateAug 28, 2026
Next Earnings DateApr 1, 2027
Ex-Dividend Date―
Financial Position
Kontafarma China Holdings Ltd as a current ratio of 0.79, with Debt / Equity ratio of 37.19%
Current Ratio0.79
Quick Ratio0.59
Debt to Market Cap0.47
Net Debt to EBITDA-0.91
Interest Coverage Ratio-22.57
Taxes
In the past 12 months, Kontafarma China Holdings Ltd has paid 27.83M in taxes.
Income Tax27.83M
Effective Tax Rate-0.06
Enterprise Valuation
Kontafarma China Holdings Ltd EV to EBITDA ratio is -1.97, with an EV/FCF ratio of 5.63.
EV to Sales0.33
EV to EBITDA-1.97
EV to Free Cash Flow5.63
EV to Operating Cash Flow3.90
Balance Sheet
Kontafarma China Holdings Ltd has HK$67.62M in cash and marketable securities with HK$189.76M in debt, giving a net cash position of -HK$122.14M billion.
Cash & Marketable SecuritiesHK$67.62M
Total DebtHK$189.76M
Net Cash-HK$122.14M
Net Cash Per Share-HK$0.02
Tangible Book Value Per ShareHK$0.04
Margins
Gross margin is 51.79%, with operating margin of -26.55%, and net profit margin of -46.77%.
Gross Margin51.79%
Operating Margin-26.55%
Pretax Margin-49.71%
Net Profit Margin-46.77%
EBITDA Margin-16.59%
EBIT Margin-26.55%
Analyst Forecast
The average price target for Kontafarma China Holdings Ltd is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast-5.20%
EPS Growth Forecast41.38%